ArticleOncotarget2016

Loss of AIM2 expression promotes hepatocarcinoma progression through activation of mTOR-S6K1 pathway.

Xiaomin Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.